Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. (CLBS) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 177 transactions totaling $427.5K, demonstrating a bullish sentiment with $122.9K in net insider flow. The most recent transaction on Sep 1, 2022 involved a transaction of 69,742 shares valued at $34.9K.
CLBS Insider Activity Summary
Who Is Buying CLBS Stock?
No significant insider buying has been recorded for CLBS in the recent period.
Who Is Selling CLBS Stock?
No significant insider selling has been recorded for CLBS in the recent period.
Is Caladrius Biosciences, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CLBS is bullish with an Insider Alignment Score of 64/100 and a net flow of $122.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CLBS Frequently Asked Questions
Understanding CLBS Insider Activity
Insider trading at Caladrius Biosciences, Inc. (CLBS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading CLBS stock, having executed 177 transactions in the past 90 days. The most active insider is David J. Mazzo (Executive), who has made 36 transactions totaling $939.3K.
Related Tools
Track Caladrius Biosciences, Inc. Insider Activity
Get notified when executives and directors at CLBS file new Form 4 transactions